This company, established in the early 1980s in South Asia, has a strong focus on innovative drug delivery systems (NDDS). With over three decades of experience, it boasts multiple globally patented technologies and has grown into a significant player in the pharmaceutical sector. The company's portfolio includes a diverse range of products in therapeutic areas like pain management, gynecology, and critical care. It also develops nutraceuticals and nutritional supplements. The company offers a variety of dosage forms, including oral, injectable, and potentially liquid forms. They manufacture products in state-of-the-art facilities, adhering to stringent GMP standards. These facilities hold approvals from international regulatory agencies, including WHO, PIC/S, and ANVISA, and are currently pursuing EU and USFDA certifications. The company's footprint extends across key regions, including Asia, Africa, Latin America, and the CIS. This global reach is further strengthened by a dedicated regulatory, operational, marketing, and business development teams. The company actively engages in licensing agreements with multinational and regional players, demonstrating its commitment to innovation and partnership.

This pharmaceutical company specializes in manufacturing a wide range of dosage forms including capsules, tablets, dry injections, oral solutions, and liquid injectables. They appear to have a strong focus on respiratory medications, pain management products (like those containing piroxicam), and gastrointestinal treatments. The company boasts multiple production facilities and is actively pursuing certifications like FDA, NMA, MHRA, and Russian Federation approvals, indicating a commitment to global markets. They emphasize their quality standards and are dedicated to research and development. While they primarily export products, their website mentions offering contract manufacturing services.

This company is a global manufacturer of essential lifesaving medicaments, specializing in high-tech parenteral and oral formulations. Established in 1984, it has grown from a small family business to a multinational corporation with over 2000 employees across 70 markets. Their expertise spans various therapeutic areas including anaesthesiology, critical care, pain management, gynaecology, ophthalmology, orthopaedics, oncology, and dermatology. They offer a diverse product portfolio of over 500 products, including injectables, infusions, and other dosage forms. The company prides itself on its commitment to quality, innovation, ethics, and transparency. They maintain GMP certifications and hold patents for several products. Their manufacturing sites are strategically located across key regions like the EU and North America.